CDK 抑制剂 CR8 作为一种分子粘合剂降解剂,可消耗环素 K
Mikołaj Słabicki1,2,3, Zuzanna Kozicka4,5, Georg Petzold4
1Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Nature
|June 5, 2020
概括
研究人员发现了一种新的方法来发现分子降解剂, 他们确定了CR8,一种循环素依赖性激酶 (CDK) 抑制剂,作为一种降解循环素K的新型分子,为药物发现提供了新的策略.
科学领域:
- 生物化学
- 药理学
- 癌症学
背景情况:
- 分子粘合剂是诱导蛋白质降解的化合物,通过劫持E3泛酸酶机制.
- 这些降解剂为向以前无法治疗的蛋白质提供了有希望的治疗策略.
- 目前分子粘剂的发现方法主要是偶然的,限制了它们的临床应用.
研究的目的:
- 通过数据库挖掘系统地识别新的分子降解剂.
- 研究CR8作为分子的作用机制.
- 将现有抑制剂转化为分子合剂的更广泛策略.
主要方法:
- 系统挖掘大规模数据集,将小分子细胞毒性与癌细胞系中的E3酶表达相关联.
- 生物化学测试以阐明CR8,CDK12-cyclin K和DDB1之间的相互作用.
- 蛋白质降解研究以确认环素K的无处不在和清除.
主要成果:
- 鉴定CR8,一个循环素依赖性激酶 (CDK) 抑制剂,作为一种新型分子降解剂.
- 在没有基质受体的情况下,CR8诱导了涉及CDK12-cyclin K和DDB1的三元复合体,导致cyclin K降解.
- 证明抑制剂的化学修饰可以产生分子属性.
结论:
- CR8是一种具有潜在治疗应用的新型分子降解剂.
- 这项研究提出了一种发现分子合物的系统方法.
- 修改现有的抑制剂为开发新的分子降解剂提供了可行的策略.
相关概念视频
02:34Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
00:50Anaphase Promoting Complex
3.3K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.3K
02:39Positive Regulator Molecules
6.4K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
6.4K
01:45Positive Regulator Molecules
132.9K
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
132.9K
02:15M-Cdk Drives Transition Into Mitosis
6.1K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.1K
02:17Separation of Sister Chromatids
4.2K
At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
At the onset of anaphase, separase, a proteolytic enzyme, is...
4.2K